Abstract
SOCS2, a member of suppressor of cytokine signaling (SOCS) family, is a negative regulator of the signal pathway Janus kinase/signal transducers and activators of transcription (JAK/STAT). Growth hormone (GH) could stimulate lipolysis in adipose tissue. To demonstrate the specific influence of SOCS2 on porcine adipocytes differentiation and lipid metabolism induced by GH, we induced porcine primary adipocytes with 500 ng/ml GH and then tested the triglyceride (TG) accumulation and mRNA expressions of crucial genes in lipid metabolism like peroxisome proliferator-activated receptor gamma (PPARγ), fatty acid synthase (FAS), adipose triglyceride lipase (ATGL), hormone-sensitive lipase (HSL), SOCS2 and SOCS3. Then we retested these genes expressions in different time point after further treatment that over expressed SOCS2 in primary adipocytes and treated with 500 ng/ml GH. Results showed 500 ng/ml GH significantly restrained the porcine primary adipocytes differentiation. Specifically, 0.5 h after the induction with GH, accumulation of TG began to increase, and turned down since 8 h after. GH could promote PPARγ and FAS expressions during earlier stage (0–1 h), restrain from 4 h. However, ATGL and HSL mRNA expressions were stabile increasing. The expression of SOCS2 increased steadily after GH stimulation while SOCS3 expression was instantaneous rise. Overexpression of SOCS2 significantly decreased GH-induced the increase of PPARγ, FAS, ATGL and HSL mRNA expressions in earlier stage (0–1 h), as well as FAS and ATGL protein expression. Otherwise SOCS2 overexpression significantly decreased signal transducers and activators of transcription 3 (STAT3), signal transducers and activators of transcription 5 (STAT5) mRNA expressions and tyrosine phosphorylation levels with GH stimulation. At the same time SOCS3 mRNA kept in a lower level in Ad-SOCS2 transfected adipocytes. In conclusion, SOCS2 might be an important negative regulator of GH signaling in porcine adipocytes, which would provide the ground work for the mechanism of SOCS2 regulation fat metabolism.
Similar content being viewed by others
References
Starr R, Willson TA, Viney EM, Murray LJ, Rayner JR, Jenkins BJ, Gonda TJ, Alexander WS, Metcalf D, Nicola NA, Hilton DJ (1997) A family of cytokine-inducible inhibitors of signaling. Nature 387:917–921
Naka T, Narazaki M, Hirata M, Matsumoto T, Minamoto S, Aono A, Nishimoto N, Kajita T, Taga T, Yoshizaki K, Akira S, Kishimoto T (1997) Structure and function of a new STAT-induced STAT inhibitor. Nature 387:924–929
Endo TA, Masuhara M, Yokouchi M, Suzuki R, Sakamoto H, Mitsui K, Matsumoto A, Tanimura S, Ohtsubo M, Misawa H, Miyazaki T, Leonor N, Taniguchi T, Fujita T, Kanakura Y, Komiya S (1997) A new protein containing an SH2 domain that inhibits JAK kinases. Nature 387:921–924
Krebs DL, Hilton DJ (2001) SOCS proteins: negative regulators of cytokine signaling. Stem Cells 19(5):378–387
Ouyang X, Fujimoto M, Nakagawa R, Serada S, Tanaka T, Nomura S, Kawase I, Kishimoto T, Naka T (2006) SOCS-2 interferes with myotube formation and potentiates osteoblast differentiation through upregulation of JunB in C2C12 cells. J Cell Physiol 207(2):428–436
Zhang Y, Zhao J, Zhang H, Gai YCH, Wang LL, Li FM, Yang JL, Qiu LM, Song LSH (2010) The involvement of suppressors of cytokine signaling 2 (SOCS2) in immune defense responses of Chinese mitten crab Eriocheir sinensis. Dev Compar Immunol 34:42–48
Thangavel C, Shapiro BH (2007) A molecular basis for the sexually dimorphic response to growth hormone. Endocrinology 148(6):2894–2903
Woelfle J, Rotwein P (2003) In vivo regulation of growth hormone-stimulated gene transcription by STAT5b. Am J Physiol Endocrinol Metab 286:393–401
Vidal OM, Merino R, Rico-Bautista E, Fernandez-Perez L, Chia Dennis J, Woelfle J, Ono M, Lenhard B, Norstedt G, Rotwein P, Flores-Morales A (2006) In vivo transcript profiling and phylogenetic analysis identifies SOCS2 as a direct STAT5b target in liver. Mol Endocrinol. doi:10.1210/me.2006-0096 (on line)
Krebs DL, Hilton DJ (2000) SOCS: physiological suppressors of cytokine signaling. J Cell Sci 113(16):2813–2819
Metcalf D, Greenhalgh CJ, Viney E, Metcalf D, Greenhalgh CJ, Viney E, Willson TA, Starr R, Nicola NA, Hilton DJ, Alexander WS (2000) Gigantism in mice lacking suppressor of cytokine signalling-2. Nature 405:1069–1073
Greenhalgh CJ, Rico-Bautista E, Lorentzon M, Thaus AL, Morgan PO, Willson TA, Zervoudakis P, Metcalf D, Street I, Nicola NA, Nash AD, Fabri LJ, Norstedt G, Ohlsson C, Flores-Morales A, Alexander WS, Hilton DJ (2005) SOCS2 negatively regulates growth hormone action in vitro and in vivo. J Clin Invest 115:397–406
Johansen T, Richelsen B, Hansen HS, Din N, Malmlof K (2003) Growth hormone-mediated breakdown of body fat: effects of GH on lipases in adipose tissue and skeletal muscle of old rats fed different diets. Horm Metab Res 35(4):243–250
Fain JN, Cheema P, Tichansky DS, Madan AK (2008) Stimulation of human omental adipose tissue lipolysis by growth hormone plus dexamethasone. Mol Cell Endocrinol 295(1–2):101–105
Lonnqvist F, Krief S, Strosberg AD, Nyberg S, Emorine LJ, Arner P (1993) Evidence for a functional beta 3-adrenocept- or in man. Pharmacology 110(3):929–936
Hsu JM, Ding ST (2003) Effect of polyunsaturated fatty acids on the expression of transcription factor adipocyte determination and differentiation-dependent factor 1 and of lipogenic and fatty acid oxidation en zymes in porcine differentiating adipocytes. Br J Nutr 90(3):507–513
Kawai M, Namba N, Mushiake S, Etani Y, Nishimura R, Makishima M, Ozono K (2007) Growth hormone stimulates adipogenesis of 3T3-L1 cells through activation of the Stat5a/5b-Ppargamma pathway. J Mol Endocrinol 38:19–34
Harp JB, Franklin D, Vanderpuije AA, Gimble JM (2001) Differential expression of signal transducers and activators of transcription during human adipogenesis. Biochem Biophys Res Commun 281:907–912
Teglund S, McKay C, Schuetz E, Deursen JM, Stravopodis D, Wang D, Brown M, Bodner S, Grosveld G, Ihle JN (1998) Stat5a and Stat5b proteins have essential and nonessential, or redundant, roles in cytokine responses. Cell 93:841–850
Louveau I, Gondret F (2004) Regulation of development and metabolism of adipose tissue by growth hormone and the insulin-like growth factor system. Domestic Animal Endocrinol 27(3):241–255
Yang SJ, Xu CQ, Wu JW, Yang GS (2010) SOCS3 inhibits insulin signaling in porcine primary adipocytes. Mol Cell Biochem 345:45–52
Hennighausen L, Robinson GW (2008) Interpretation of cytokine signaling through the transcription factors Stat5a and Stat5b. Genes Dev 22:711–721
Yang S, Mulder H, Holm C, Eden S (2004) Effects of growth hormone on the function of beta-adrenoceptor subtypes in rat adipocytes. Obes Res 12(2):330–339
Herrington J, Smit LS, Schwartz J, Carter-Su C (2000) The role of STAT proteins in growth hormone signaling. Oncogene Res 19(21):2585–2597
Waxman DJ, O’Connor C (2006) Growth hormone regulation of sex-dependent liver gene expression. Mol Endocrinol 20:2613–2629
Plockinger U, Reuter T (2008) Pegvisomant increases intra-abdominal fat in patients with acromegaly: a pilot study. Endocrinology 158(4):467–471
Paul C, Seiliez I, Thissen JP, Le CA (2000) Regulation of expression of the rat SOCS-3 gene in hepatocytes by growth hormone, interleukin-6 and glucocorticoids mRNA analysis and promoter characterization. Eur J Biochem 267(19):5849–5857
Sun C, Wang L, Yan J, Liu SM (2012) Calcium ameliorates obesity induced by high-fat diet and its potential correlation with p38 MAPK pathway. Mol Biol Rep 39(2):1755–1763
Rico BE, Negrin MC, Novoa MJ, Fernandez PL, Flores MA (2004) Down regulation of the growth hormoneinduced Janus kinase 2/signal transducer and activator of transcription 5 signaling pathway requires an intact actin cytoskeleton. Exp Cell Res 294(1):269–280
Dif F, Saunier E, Demeneix B, Kelly PA, Edery M (2001) Cytokine-inducible SH2-containing protein suppresses PRL signaling by binding the PRL receptor. Endocrinology 142(12):5286–5293
Tannahill GM, Elliott J, Barry AC, Hibbert L, Cacalano NA, Johnston JA (2005) SOCS-2 can enhance interleukin-2 (IL-2) and IL-3 signaling by accelerating SOCS-3 degradation. Mol Cell Biol 25(20):9115–9126
Lavens D, Montoye T, Piessevaux J, Zabeau L, Vandekerckhove J, Gevaert K, Becker W, Eyckerman S, Tavernier J (2006) A complex interaction pattern of CIS and SOCS2 with the leptin receptor. J Cell Sci 119:2214–2224
Sun C, Qi RL, Wang L, Yan J, Wang Y (2012) p38 MAPK regulates calcium signal-mediated lipid accumulation through changing VDR expression in primary preadipocytes of mice. Mol Biol Rep 39(3):3179–3184
Piessevaux J, Lavens D, Montoye T, Wauman J, Catteeuw D, Vandekerckhove J, Belsham D, Peelman F, Tavernier J (2006) Functional cross-modulation between SOCS proteins can stimulate cytokine signaling. J Biol Chem 281(44):32953–32966
Acknowledgments
This study was supported by National Nature Science Foundation of China (No. 30871785, 31172185) and the fund of International Science and Technology Cooperation. We thank Dr. Bin Wu and Dr. J. Gale for their suggestions and correction of the English manuscript.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Yang, H.L., Sun, C., Sun, C. et al. Effect of suppressor of cytokine signaling 2 (SOCS2) on fat metabolism induced by growth hormone (GH) in porcine primary adipocyte. Mol Biol Rep 39, 9113–9122 (2012). https://doi.org/10.1007/s11033-012-1783-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11033-012-1783-9